{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Delle Donne R"],"funding":["Associazione Italiana per la Ricerca sul Cancro","Ministero dell'Istruzione, dell'Università e della Ricerca"],"pagination":["780"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9345969"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["5(1)"],"pubmed_abstract":["Glioblastoma multiforme (GBM) is the most frequent and aggressive form of primary brain tumor in the adult population; its high recurrence rate and resistance to current therapeutics urgently demand a better therapy. Regulation of protein stability by the ubiquitin proteasome system (UPS) represents an important control mechanism of cell growth. UPS deregulation is mechanistically linked to the development and progression of a variety of human cancers, including GBM. Thus, the UPS represents a potentially valuable target for GBM treatment. Using an integrated approach that includes proteomics, transcriptomics and metabolic profiling, we identify praja2, a RING E3 ubiquitin ligase, as the key component of a signaling network that regulates GBM cell growth and metabolism. Praja2 is preferent"],"journal":["Communications biology"],"pubmed_title":["Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth."],"pmcid":["PMC9345969"],"funding_grant_id":["IG2018-ID22062 and IG-23068","D26C18000260005"],"pubmed_authors":["Giurato G","Rizzo F","Delle Donne R","Arcella A","Iannucci R","Rinaldi L","Senatore E","Oliva MA","Scaloni A","Sellitto A","Castaldo S","Borzacchiello D","Scala G","D'Ambrosio C","Weisz A","Ambrosino C","Feliciello A","Garbi C","Chiuso F","Campani V","De Rosa G","Lignitto L","Nele V","Roberto L"],"additional_accession":[]},"is_claimable":false,"name":"Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth.","description":"Glioblastoma multiforme (GBM) is the most frequent and aggressive form of primary brain tumor in the adult population; its high recurrence rate and resistance to current therapeutics urgently demand a better therapy. Regulation of protein stability by the ubiquitin proteasome system (UPS) represents an important control mechanism of cell growth. UPS deregulation is mechanistically linked to the development and progression of a variety of human cancers, including GBM. Thus, the UPS represents a potentially valuable target for GBM treatment. Using an integrated approach that includes proteomics, transcriptomics and metabolic profiling, we identify praja2, a RING E3 ubiquitin ligase, as the key component of a signaling network that regulates GBM cell growth and metabolism. Praja2 is preferent","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Aug","modification":"2026-07-15T22:24:21.444Z","creation":"2025-04-22T16:32:56.79Z"},"accession":"S-EPMC9345969","cross_references":{"pubmed":["35918402"],"doi":["10.1038/s42003-022-03639-8"]}}